Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic

BACKGROUND: Since treatment for latent cryptococcal infection (CI) before starting antiretroviral therapy (ART) reduces mortality in HIV-infected subjects, screening for cryptococcal antigen (CrAg) in blood is recommended for individuals with CD4 cell counts < 100 cells/µL in regions with high CI...

Descripción completa

Detalles Bibliográficos
Autores principales: Reepalu, Anton, Balcha, Taye T., Yitbarek, Tadele, Jarso, Godana, Sturegård, Erik, Björkman, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656181/
https://www.ncbi.nlm.nih.gov/pubmed/26597840
http://dx.doi.org/10.1186/s13104-015-1707-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656181/
https://www.ncbi.nlm.nih.gov/pubmed/26597840
http://dx.doi.org/10.1186/s13104-015-1707-6

Ejemplares similares